CClinicalTrials.gg
CompletedNCT03049982Updated Feb 7, 2019

A Study for Obstructive Sleep Apnea Using a New At-Home Sleep Test

An interventional study of Auto-titrating mandibular positioner test in Obstructive Sleep Apnea, sponsored by Zephyr Sleep Technologies. Completed at 1 site in United States. Open to participants aged 18 Years and older. Per ClinicalTrials.gov, last updated 2019-02-07.

Sponsored by Zephyr Sleep Technologies · Not applicable, Interventional, and Other

Phase
Not applicable
Study type
Interventional
Enrollment
28
Allocation
Not applicable
Ages
18 Years and older
Sex
All
01

Study summary

The purpose of the study is to test the workflow of an auto-titrating mandibular positioner in its intended setting. Participants with obstructive sleep apnea will use the device to determine their eligibility for oral appliance therapy and provide feedback on usability of the device.

Read the detailed description

One treatment for obstructive sleep apnea is oral appliance therapy during sleep, in which an appliance that covers the upper and lower teeth acts to pull the lower jaw forward, opening the throat passage and allowing for normal breathing. However, oral appliance therapy does not treat sleep apnea effectively in all individuals. In order to identify those individuals for whom oral appliance therapy will work, the study sponsor has developed an investigational device called an auto-titrating mandibular positioner.

The device automatically pulls the lower jaw forward in response to respiratory events while the individual sleeps. Study participants will learn the outcome of their sleep tests and will provide feedback on the ease of use of the device.

02

Conditions studied

  • Obstructive Sleep Apnea

Keywords

  • Oral appliance therapy
03

In context

Apnea

1,422 studies on the registry are indexed under Apnea; 158 are open to participants now.

This study's enrollment of 28 is below the median of 50 across 965 interventional studies indexed under Apnea.

Browse Apnea studies →

Lead sponsor

Zephyr Sleep Technologies is the lead sponsor of 8 studies on the registry; none are open to participants now.

Counted across the registry records on this site, refreshed daily.

04

Who can participate

Ages eligible
18 Years and older
Sexes eligible
All
Accepts healthy volunteers
No

Inclusion criteria

  1. Minimum 18 years of age
  2. Participant has been deemed suitable for oral appliance therapy
  3. Prescription for oral appliance
  4. Adequate range of motion
  5. Adequate dentition
  6. Ability to understand and provide informed consent
  7. Ability and willingness to meet the required schedule

Exclusion criteria

Exclusion Criteria:

  1. Loose teeth or advanced periodontal disease
  2. Full dentures
05

Study design

Phase
Not applicable
Primary purpose
Other
Allocation
Not applicable
Intervention model
Single group
Masking
None (open label)
Enrollment
28 participants (actual)

Study arms

  • Other
    AMP test group

    All individuals will undergo a test using the auto-titrating mandibular positioner.

    Device: Auto-titrating mandibular positioner test

Interventions

  • DeviceAuto-titrating mandibular positioner test

    Participants will undergo a theragnostic test using the auto-titrating mandibular positioner to determine if they are eligible candidates to use oral appliance therapy for their obstructive sleep apnea. The device works by moving the lower jaw forward in response to respiratory events while the participant sleeps. All participants will undergo the same test.

06

What researchers measure

Primary outcomes

  1. Integration of the device into the existing workflow of a dental sleep medicine practice

    Data for this outcome are largely directed at the study staff, not study participants. Data collected for this outcome include: time required to evaluate eligibility for device use, time required to prepare device for use.

    Time frame: 6 months

  2. Convenience/feasibility of carrying out a multi-night AMP study in the home

    Participants will complete a questionnaire following their AMP tests to collect data on participants' opinion of the device (includes opinion of various device components, ease of use of the device).

    Time frame: 6 months

  3. Feasibility of instructing the participant on the use of the AMP device at the practitioner's office

    Data for this outcome are directed at study staff, not study participants. Data collected will include feedback on ease of training participants on device use. Participants will be asked if they felt they received adequate training from the study staff via a questionnaire.

    Time frame: 6 months

Secondary outcomes

  1. Time to therapy

    Time to therapy will be evaluated by tracking the time from the first consultation at the dentist's office to the setting of the temporary appliance (for individuals whose tests indicate they are predicted candidates for oral appliance therapy).

    Time frame: 6 months

  2. Number of study visits

    The number of study visits will be recorded. This data will be collected from study records and does not require input from the participant.

    Time frame: 6 months

  3. Length of study visits

    The length of each visit (minutes) will be recorded. This data will be collected from study records and does not require input from the participant.

    Time frame: 6 months

  4. Ease of scheduling study visits

    The ease of scheduling will be discussed with the study staff to collect data on ease of integration of the device into the practice.

    Time frame: 6 months

07

Study locations

1 site
  • Encino Center for Sleep and TMJ Disorders
    Encino, California 91436, United States
08

References and documents

Individual participant data

Plan to share: No

No publications or documents are linked to this record.

09

Updates

Tracking since Sep 25, 2026
No changes since tracking began. The registry record was last updated on Feb 7, 2019, before this site started recording changes on Sep 25, 2026. Its history is on ClinicalTrials.gov ↗
10

Registry details

Key details

Study ID
NCT03049982
Lead sponsor
Zephyr Sleep Technologies
Responsible party
Sponsor
First posted
Feb 10, 2017
Start date
Feb 7, 2017
Primary completion
Oct 17, 2018
Completion
Oct 17, 2018
Last update
Feb 7, 2019

Oversight

Data monitoring committee
Yes
FDA-regulated drug
No
FDA-regulated device
No
View the source record on ClinicalTrials.gov ↗

Not currently enrolling

This study is completed, as verified in Feb 2019. You cannot join it, but the record below documents what was studied.

Follow this study

Get an email when the registry record changes — status, dates, results — or when someone posts here.

Sign in to follow

Discussion

Questions and observations about this study, from anyone following it. Not medical advice, and not a channel to the study team — their contact details are on the registry record.

Sign in to join the discussion. Reading takes no account; posting does. You choose a display name, and a pseudonym is the default.

Nothing here yet. If you are running this trial, taking part in it, or weighing whether to, this is the place to say so.

Start the discussion